Amgen Financial Ratios

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

We suggest you to use Amgen Inc fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Amgen Inc is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found thirty-eight available fundamental indicators for Amgen Inc which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Amgen Inc fundamentals including its EBITDA, Cash Flow from Operations and the relationship between Price to Book and Total Debt . Given that Amgen Inc has Price to Earning of 68.23 times, we suggest you validate Amgen Inc prevailing market performance to make sure the company can sustain itself down the road.Use Amgen to protect against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Amgen to be traded at $181.71 in 30 days

Amgen Inc Valuation Over Time

Enterprise Value

Amgen Company Summary

Amgen competes with Vertex Pharmaceuticals, Endo International, Abbott Laboratories, Allergan plc, and BIO RAD. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.

Amgen Shares Owned by Insiders vs Profit Margin

Amgen Inc is rated below average in shares owned by insiders category among related companies. It is number one stock in profit margin category among related companies fabricating about  57.73  of Profit Margin per Shares Owned by Insiders.

Amgen Inc Systematic Risk

The output start index for this execution was six with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Amgen Inc correlated with the market. If Beta is less then 0 Amgen generally moves in the opposite direction as compared to the market. If Amgen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amgen Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amgen is generally in the same direction as the market. If Beta > 1 Amgen moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 39% 

Chance of Financial Distress

Amgen Inc has less than 39 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


Amgen Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth


Compare Amgen To Peers
Robert Bradway Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee
Brian McNamee Executive Vice President - Full Potential Initiatives
More Executives

Opportunity Range

February 20, 2018 Opportunity Range